Abstract: The present invention relates to compounds that selectively inhibit influenza A virus group (1) sialidases and are therefore potential anti-influenza agents.

Abstract: The present invention relates to novel thioglycosides of D-galactofuranose that have an antimicrobial action, methods for their synthesis, pharmaceutical compositions containing them and methods for the treatment of patients suffering microbial infection.

Abstract: A compound of general formula (I): wherein R1 and R2 may be the same or different and are selected from the group consisting of hydrogen, optionally substituted C4-30 alkyl and optionally substituted C4-30 alkenyl, provided that R1 and R2 may not both be hydrogen, or R1 and R2 together with the nitrogen atom from which they depend form a saturated or unsaturated, optionally substituted heterocyclic group which may include additional heteroatoms selected from the group consisting of O, N and S, or R1 and R2 together with the nitrogen atom from which they depend form an optionally substituted lactam moiety; X1 is selected from the group consisting of OR3, SR3, NR3R?3, hydrogen, halogen, CN, C(O)NR3R?3, C(O)OR3, OSO3R3, OPO3R3, NNR3R?3, SNR3R?3, NHSR3, SSR3 and substituted alkyl; X2 is selected from the group consisting of OR4, SR4, NR4R?4, hydrogen, halogen, CN, C(O)NR4R?4, C(O)OR4, OSO3R4, OPO3R4, NNR4R?4, SNR4R?4, NHSR4, SSR4 and substituted alkyl; X3 is selected from the group consisting of OR5, SR